Notifying FDA of a Permanent Discontinuance or Interruption in Manufacturing of a Device Under Section 506J

FDA Guidance FDA CDRH/CBER 2025-01-01
Home/ Resources/ Notifying FDA of a Permanent…

Summary

Final Guidance
Manufacturing

This FDA guidance document provides recommendations and regulatory information for the medical device industry. It was issued by the Center for Devices and Radiological Health (CDRH) in collaboration with the Center for Biologics Evaluation and Research (CBER).

Document Details

  • Issuing Authority: FDA CDRH/CBER
  • Status: Final
  • Topic Area: Manufacturing
  • Date: 2025-01-01

Access the Full Document

View on FDA.gov →

Source: U.S. Food and Drug Administration (FDA). This content is provided for informational purposes. Always refer to the official FDA document for the most current version.

Document Details

Document IDFDA-CDRH-NOTIFYING-FDA-OF-A-PERMANENT-DISCONTINUANCE-OR-INT
TypeFDA Guidance
AuthorityFDA CDRH/CBER
Publication Date2025-01-01

Download Document

Download PDF

Categories

Quick Info

TypeFDA Guidance
Published ByFDA CDRH/CBER
Date2025-01-01

Regulatory Support

Need help understanding this guidance document?

Contact Us
Scroll to Top